var title_f41_42_42656="C difficile colitis CT";
var content_f41_42_42656=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57812&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57812&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudomembranous colitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 299px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan shows marked thickening of the wall of the sigmoid colon (arrows). This appearance is not specific for pseudomembranous colitis and may be seen with any form of colitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42656=[""].join("\n");
var outline_f41_42_42656=null;
var title_f41_42_42657="Patient information: Group B streptococcal disease (The Basics)";
var content_f41_42_42657=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"14\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/39/33395\">",
"         Patient information: Avoiding infections in pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/47/20210\">",
"         Patient information: Urinary tract infections in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?31/18/32036\">",
"         Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/7/17522\">",
"         Patient information: Vaccination during pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Group B streptococcal disease (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/group-b-streptococcal-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25198140\">",
"      <span class=\"h1\">",
"       What is group B streptococcal disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Group B streptococcal disease is an infection caused by bacteria called &ldquo;group B streptococcus,&rdquo; or &ldquo;GBS&rdquo; for short. In most healthy adults, GBS is harmless. But in pregnant women and their babies, a GBS infection can be serious.",
"     </p>",
"     <p>",
"      This article is about GBS infection in pregnant women and their babies.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198155\">",
"      <span class=\"h1\">",
"       What are the symptoms of GBS infection in pregnant women?",
"      </span>",
"      &nbsp;&mdash;&nbsp;GBS infection often causes no symptoms. When it does cause symptoms, the symptoms depend on the organs involved. Common types of GBS infection include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bladder infection - The symptoms of a bladder infection include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Pain or a burning feeling when you urinate",
"       </li>",
"       <li>",
"        The need to urinate often",
"       </li>",
"       <li>",
"        The need to urinate suddenly or in a hurry",
"       </li>",
"       <li>",
"        Blood in the urine",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Kidney infection &ndash; The symptoms of a kidney infection can include the symptoms of a bladder infection, but they can also include fever, back pain, and nausea and vomiting.",
"       </li>",
"       <li>",
"        Amniotic infection (also called intraamniotic infection) &ndash; The symptoms of an amniotic infection include",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Fever",
"       </li>",
"       <li>",
"        Tenderness in the lower part of the belly, where the uterus is found",
"       </li>",
"       <li>",
"        A fast heart rate in the mother or the fetus (unborn baby)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198170\">",
"      <span class=\"h1\">",
"       Is there a test for GBS infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors can take samples of different body fluids and then check whether any GBS bacteria grow in those samples over time. This is called doing a &ldquo;culture.&rdquo;",
"     </p>",
"     <p>",
"      Most doctors recommend that all women have a urine culture for GBS early in pregnancy. Expert groups also recommend that all pregnant women have GBS cultures done on samples from the vagina and rectum at 35 to 37 weeks of pregnancy. Women who test positive for GBS can take antibiotics to treat the infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198185\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse right away if you are pregnant and have any signs of infection, such as the symptoms listed above. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198200\">",
"      <span class=\"h1\">",
"       What problems can GBS cause to a mother or her baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;In the mother, GBS can cause infections of the amniotic fluid or uterus, and early delivery (called preterm birth). In newborns, GBS can cause serious infections in the lungs, blood, brain and spinal cord, bones and joints, and skin and soft tissues (such as muscle or fat).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198215\">",
"      <span class=\"h1\">",
"       How is GBS disease treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment for pregnant women involves getting an antibiotic into a vein (IV) during labor. This protects the mother and her baby from having problems caused by GBS.",
"     </p>",
"     <p>",
"      If you are treated for GBS during labor, you and the baby&rsquo;s healthcare team should watch the baby for signs of infection after he or she is born. In a baby, the signs of infection include fever or low temperature, poor feeding, trouble breathing, being irritable, and being very sleepy.",
"     </p>",
"     <p>",
"      If your baby&rsquo;s doctor thinks your baby has an infection, he or she might order blood tests, X-rays, or other tests. Babies who develop GBS infection are treated with antibiotics through an IV for at least 10 days.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25198230\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/39/33395?source=see_link\">",
"       Patient information: Avoiding infections in pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/47/20210?source=see_link\">",
"       Patient information: Urinary tract infections in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=see_link\">",
"       Patient information: Vaccination during pregnancy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/18/32036?source=see_link\">",
"       Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/42/42657?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 17106 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-652B83C886-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42657=[""].join("\n");
var outline_f41_42_42657=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198140\">",
"      What is group B streptococcal disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198155\">",
"      What are the symptoms of GBS infection in pregnant women?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198170\">",
"      Is there a test for GBS infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198185\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198200\">",
"      What problems can GBS cause to a mother or her baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198215\">",
"      How is GBS disease treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25198230\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/39/33395?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/18/32036?source=related_link\">",
"      Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/47/20210?source=related_link\">",
"      Patient information: Urinary tract infections in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=related_link\">",
"      Patient information: Vaccination during pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_42_42658="Removal of round ear foreign body";
var content_f41_42_42658=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Removal of a spherical external auditory canal foreign body",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A right angle hook is carefully advanced beyond the spherical bead and slowly withdrawn.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from illustration by&nbsp;Glenn Isaacson MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42658=[""].join("\n");
var outline_f41_42_42658=null;
var title_f41_42_42659="Vitamin B complex: Patient drug information";
var content_f41_42_42659=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Vitamin B complex: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25762?source=see_link\">",
"     see \"Vitamin B complex: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F13817330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Accidental overdose of drugs that have iron in them is a leading cause of deadly poisoning in children younger than 6 years of age. Keep away from children. If this drug is taken by accident, call a doctor or poison control center right away.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10013404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692172",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vitamins are needed for growth and good health.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10013403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10013408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10013409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10013411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10013406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694925",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gevrabon&reg; liquid: Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10013407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10013412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10013413\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11905 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-8BB6C55152-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42659=[""].join("\n");
var outline_f41_42_42659=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13817330\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013404\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013403\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013408\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013409\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013411\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013406\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013407\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013412\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10013413\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?25/10/25762?source=related_link\">",
"      Vitamin B complex: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_42_42660="Abiraterone: Patient drug information";
var content_f41_42_42660=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Abiraterone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/29/44503?source=see_link\">",
"     see \"Abiraterone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12805570\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zytiga&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F13203911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zytiga&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F12806535\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat prostate cancer.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F12806523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434942",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to abiraterone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a woman.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F12806525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4066330",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have adrenal problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434948",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not let women who are pregnant or of childbearing age touch the tablets without wearing gloves.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434949",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having sex and your partner is pregnant or gets pregnant, use a latex condom during care and for 1 week after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F12806538\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697889",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain or heartburn.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698247",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle or joint pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F12806527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434950",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling on legs or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F12806537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434945",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with prednisone as you have been told by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F12806524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434946",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you miss a dose, wait until the next day to take your normal dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3434947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you miss 2 doses, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F12806540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F12806528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16459 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-0E8BE10A25-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42660=[""].join("\n");
var outline_f41_42_42660=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12805570\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13203911\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806535\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806523\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806525\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806538\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806527\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806537\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806524\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806540\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12806528\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?43/29/44503?source=related_link\">",
"      Abiraterone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_42_42661="Resec urethral diverticulum";
var content_f41_42_42661=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diverticular resection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Incision and development of periurethral fascial planes. The incision in the fascia should be over the central diameter of the diverticular lesion. B) Dissection (circumferential) of the diverticular sac to the urethral ostium. The dissection plane between the sac and the urethra may be poorly defined in the presence of substantial peridiverticular inflammation. C) Running closure of the urethral defect over a small caliber (14 Fr) urethral catheter. Avoid excessive tension or compromise of the lumen. D) Vaginal closure after periurethral reapproximation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dmochowski, D. Surgery for vesicovaginal fistula, urethrovaginal fistula, and urethral diverticulum. In: Campbell's urology, 8th ed, Walsh, PC (Ed), Saunders, Philadelphia, PA 2002. p. 1213. Copyright &copy;2002 Elsevier Science, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42661=[""].join("\n");
var outline_f41_42_42661=null;
var title_f41_42_42662="Lymphocytic thymoma Low";
var content_f41_42_42662=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F82468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F82468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Predominantly lymphocytic thymoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immature lymphocytes are predominant, compared to the epithelial cells that are hardly seen on hematoxylin and eosin stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42662=[""].join("\n");
var outline_f41_42_42662=null;
var title_f41_42_42663="Epiglottitis radiograph";
var content_f41_42_42663=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Epiglottitis: Lateral neck radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A normal epiglottis on a lateral neck radiograph, with the structures illustrated in panel B. Epiglottitis is similarly depicted radiographically (C, D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher GR, Ludwig W, Baskin MN. Atlas of Pediatric Emergency Medicine. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42663=[""].join("\n");
var outline_f41_42_42663=null;
var title_f41_42_42664="Thalidomide: Pediatric drug information";
var content_f41_42_42664=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Thalidomide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"    see \"Thalidomide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/48/44805?source=see_link\">",
"    see \"Thalidomide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708930\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F226481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Thalomid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F226482\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Thalomid&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1038544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Angiogenesis Inhibitor",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Immunosuppressant Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Tumor Necrosis Factor (TNF) Blocking Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1038576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=see_link\">",
"      see \"Thalidomide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      AIDS-related aphthous stomatitis:",
"     </b>",
"     Limited data available: Adolescents &ge;13 years: Oral: 200 mg once daily at bedtime for 4 weeks or sooner if resolution. May be increased to 200 mg twice daily if no improvement after 4 weeks. Dosing based on double-blind, placebo-controlled trial by AIDS Clinical Trials Group (n=57, age: &ge;13 years) which showed 55% healing in treatment group vs 7% in placebo (Jacobson, 1997).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Chronic graft-versus-host disease (refractory), treatment:",
"     </b>",
"     Limited data available: Children &ge;2 years and Adolescents: Oral: Initial: 3-6 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     (maximum initial daily dose: 100 mg/",
"     <b>",
"      day",
"     </b>",
"     ) at bedtime or in 2-4 divided doses before meals; may be adjusted at &ge; 2 week intervals based on patient response up to 12 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     in 3-4 divided doses (maximum daily dose: 800 mg/",
"     <b>",
"      day",
"     </b>",
"     ) (Browne, 2000; Rovelli, 1998; Wolff, 2010); one trial using initial doses of 3 mg/kg/dose every 6 hours (dose adjusted to attain goal thalidomide concentration of &ge;5 mcg/mL 2 hours postdose) (Vogelsang, 1992)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Crohn's disease/ulcerative colitis (refractory), treatment:",
"     </b>",
"     Limited data available: Children &ge;1 year and Adolescents: Oral: 0.5-3 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     (maximum daily dose: 300 mg/",
"     <b>",
"      day",
"     </b>",
"     ), usually dosed once daily in the evening; titrate to lowest effective dose after remission is achieved (Facchini, 2001; Lazzerini, 2007; Martelossi, 2004; Zheng, 2011)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Cutaneous erythema nodosum leprosum (ENL):",
"     </b>",
"     Children &ge;12 years and Adolescents: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial: 100-300 mg once daily at bedtime; may increase to 400 mg/day in severe cases or in patients who had previously required a high dose for treatment; for patients &lt;50 kg, initiate at lower end of dosage range.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: Continue initial dose until active reaction subsides then taper in 50 mg decrements every 2-4 weeks. Doses may be divided and taken 1 hour after meals. Patients who flare during tapering or with a history of requiring prolonged maintenance should be maintained on the minimum dosage necessary to control the reaction. Efforts to taper should be repeated every 3-6 months, in increments of 50 mg every 2-4 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Systemic-onset juvenile idiopathic arthritis:",
"     </b>",
"     Limited data available: Children &ge;3 years and Adolescents: Oral: Initial 2 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     , if necessary may increase at 2-week intervals to 3-5 mg/kg/",
"     <b>",
"      day",
"     </b>",
"     . Data based on a multicenter, open-labeled prospective study (n=13, age: 3-23 years); within 4 weeks, 11 of 13 patients showed improvement in JRA scores, significant decreases in ESR, and significant increase in hemoglobin (Lehman, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Chronic graft-versus-host disease (refractory), treatment:",
"     </b>",
"     Oral: Initial: 100 mg at bedtime, with dose escalation up to 400 mg/day in 3-4 divided doses (Wolff, 2010)",
"     <b>",
"      or",
"     </b>",
"     Initial: 50-100 mg 3 times daily; maximum dose: 600-1200 mg/day (Kulkarni, 2003)",
"     <b>",
"      or",
"     </b>",
"     200 mg 4 times daily (dose adjusted to goal thalidomide concentration of &ge;5 mcg/mL 2 hours postdose) (Vogelsang, 1992)",
"     <b>",
"      or",
"     </b>",
"     100-300 mg 4 times daily (Parker, 1995)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Crohn&rsquo;s disease, refractory:",
"     </b>",
"     Oral: 50-100 mg/day at bedtime (Vasiliauskas, 1999)",
"     <b>",
"      or",
"     </b>",
"     200-300 mg/day at bedtime (Ehrenpreis, 1999)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Cutaneous erythema nodosum leprosum (ENL):",
"     </b>",
"     Oral: Initial: 100-300 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Adjustments to initial dose:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Patients weighing &lt;50 kg: Initiate at lower end of the dosing range",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Severe cutaneous reaction or patients previously requiring high dose may be initiated at 400 mg/day; doses may be divided, but taken 1 hour after meals",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <i>",
"      Duration and tapering/maintenance:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Maintenance: Dosing should continue until active reaction subsides (usually at least 2 weeks), then tapered in 50 mg decrements every 2-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Patients who flare during tapering or with a history of requiring prolonged maintenance should be maintained on the minimum dosage necessary to control the reaction. Efforts to taper should be repeated every 3-6 months, in decrements of 50 mg every 2-4 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Multiple myeloma: Note:",
"     </b>",
"     Details concerning dosing for multiple myeloma with combination regimens should also be consulted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     200 mg once daily at bedtime (in combination with dexamethasone 40 mg daily on days 1-4, 9-12, and 17-20 of a 28-day treatment cycle)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     In combination with melphalan and prednisone: 200-400 mg once daily (Facon, 2007)",
"     <b>",
"      or",
"     </b>",
"     100 mg once daily (Palumbo, 2008)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for renal impairment:",
"     </b>",
"     No adjustment is required for patients with renal impairment and on dialysis (per manufacturer). In a study of six adult patients with end-stage renal disease on dialysis, although clearance was increased by dialysis, a supplemental dose was not needed (Eriksson, 2003).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Multiple myeloma: An evaluation of 29 newly diagnosed adult myeloma patients with renal failure (serum creatinine &ge;2 mg/dL) treated with thalidomide and dexamethasone (some also received cyclophosphamide) found that toxicities and efficacy were similar to patients with normal renal function (Seol, 2010). A study evaluating induction therapy with thalidomide and dexamethasone in 31 newly diagnosed adult myeloma patients with renal failure (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute), including 16 patients with severe renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute) and seven patients on chronic hemodialysis found that toxicities were similar to patients without renal impairment and that thalidomide and dexamethasone could be administered safely (Tosi, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for hepatic impairment:",
"     </b>",
"     Thalidomide does not appear to undergo significant hepatic metabolism; the pharmacokinetics of thalidomide have not been studied in patients with liver dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for toxicity:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ANC &le;750/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Withhold treatment if clinically appropriate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Multiple myeloma: Constipation, oversedation, peripheral neuropathy: Temporarily withhold or continue with a reduced dose",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F226457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Thalomid&reg;: 50 mg, 100 mg, 150 mg, 200 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F226442\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11234348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      U.S.:",
"     </b>",
"     As a requirement of the REMS program, access to this medication is restricted. Thalidomide is approved for marketing only under a special distribution program, the Thalomid REMS&trade;  (www.celgeneriskmanagment.com or 1-888-423-5436), which has been approved by the FDA. Prescribers, patients, and pharmacies  must be certified with the program to prescribe or dispense thalidomide. No more than a 4-week supply should be dispensed. Blister packs should be dispensed intact (do not repackage capsules). Prescriptions must be filled within 7 days (for females of reproductive potential) or within 30 days (for all other patients) after authorization number obtained. Subsequent prescriptions may be filled only if fewer than 7 days of therapy remain on the previous prescription. A new prescription is required for further dispensing (a telephone prescription may not be accepted.) Pregnancy testing is required for females of childbearing potential.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Canada:",
"     </b>",
"     Access to thalidomide is restricted through a controlled distribution program called RevAid&reg;. Only physicians and pharmacists enrolled in this program are authorized to prescribe or dispense thalidomide. Patients must be enrolled in the program by their physicians. Further information is available at www.RevAid.ca or by calling 1-888-738-2431.",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F10523386\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM222363.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM222363.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1038582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Administer with water, preferably at bedtime, once daily on an empty stomach, at least 1 hour after the evening meal. Doses &gt;400 mg/day may be given in 2-3 divided doses. Avoid extensive handling of capsules; capsules should remain in blister pack until ingestion. If exposed to the powder content from broken capsules or body fluids from patients receiving thalidomide, the exposed area should be washed with soap and water. For missed doses, if &lt;12 hours have passed, patient may receive dose; if &gt;12 hours have passed, wait until next dose is due.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1038564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg;C to 30&deg;C (50&deg;F to 86&deg;F). Protect from light. Keep in original package.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1038545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of multiple myeloma in combination with dexamethasone (FDA approved in ages &ge;12 years and adults); treatment and maintenance of cutaneous manifestations of erythema nodosum leprosum (ENL) (FDA approved in &ge;12 years and adults). Has also been used  in children when other therapies have failed for treatment of Crohn's disease/ulcerative colitis; refractory chronic graft-versus-host disease (cGVHD); AIDS-related aphthous stomatitis; systemic-onset juvenile idiopathic arthritis (SOJIA); various malignancies",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F226506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Thalidomide may be confused with flutamide, lenalidomide, pomalidomide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Thalomid&reg; may be confused with thiamine",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Thalomid [U.S., Canada] may be confused with Thilomide brand name for lodoxamide [Greece, Turkey]",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F226505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema, facial edema, hypotension, peripheral edema, thrombosis/embolism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation/anxiety, confusion, dizziness, fatigue, fever, headache, insomnia, malaise, motor neuropathy, nervousness, pain, sensory neuropathy, somnolence, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, dermatitis (fungal), desquamation, dry skin, maculopapular rash, nail disorder, pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperlipemia, hypocalcemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, constipation, diarrhea, flatulence, nausea, oral moniliasis, tooth pain, weight gain/loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, leukopenia, lymphadenopathy, neutropenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: AST increased, bilirubin increased, LFTs abnormal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, muscle weakness, myalgia, neck pain/rigidity, neuropathy, paresthesia, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Albuminuria, hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Dyspnea, pharyngitis, rhinitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute renal failure, alkaline phosphatase increased, ALT increased, amenorrhea, angioedema, aphthous stomatitis, arrhythmia, atrial fibrillation, bile duct obstruction, bradycardia, BUN increased, carpal tunnel, CML, creatinine clearance decreased, creatinine increased, deafness, depression, diplopia, dysesthesia, ECG abnormalities, enuresis, eosinophilia, epistaxis, erythema multiforme, erythema nodosum, erythroleukemia, exfoliative dermatitis, febrile neutropenia, foot drop, galactorrhea, granulocytopenia, gynecomastia, hearing loss, hepatomegaly, Hodgkin's disease, hypercalcemia, hyper-/hypokalemia, hypersensitivity, hypertension, hyper-/hypothyroidism, hypersensitivity, hyperuricemia, hypomagnesemia, hyponatremia, hypoproteinemia, intestinal obstruction, intestinal perforation, interstitial pneumonitis, LDH increased, lethargy, leukocytosis, loss of consciousness, lymphedema, lymphopenia, mental status changes, metrorrhagia, MI, myxedema, nystagmus, oliguria, orthostatic hypotension, pancytopenia, paresthesia, petechiae, peripheral neuritis, photosensitivity, pleural effusion, prothrombin time changes, psychosis, pulmonary embolus, pulmonary hypertension, purpura, Raynaud's syndrome, renal failure, seizure, sepsis, septic shock, sexual dysfunction, sick sinus syndrome, status epilepticus, Stevens-Johnson syndrome, stomach ulcer, stupor, suicide attempt, syncope, tachycardia, thrombocytopenia, toxic epidermal necrolysis, tumor lysis syndrome, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1038552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to thalidomide or any component; pregnancy; women of childbearing potential, unless alternative therapies are inappropriate and adequate precautions are taken to avoid pregnancy; patients unable to comply with S.T.E.P.S.&reg; program (including males)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F7710704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity reactions, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have been reported; withhold therapy and evaluate skin rashes; permanently discontinue if rash is exfoliative, purpuric, bullous, or if SJS or TEN is suspected. May cause bradycardia; in some cases, medical intervention may be required; use with caution in patients with cardiovascular disease. May cause seizures; use  with caution in patients with a history of seizures, concurrent therapy with drugs which alter seizure threshold, or conditions which predispose to seizures.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1038553\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     . Thalidomide is a known teratogen, even following a single dose",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; embryotoxic with limb defects noted from the 27th to 40th gestational day of exposure; all cases of phocomelia occur from the 27th to 42nd gestational day; fetal cardiac, gastrointestinal, bone, external ear, eye, and genitourinary tract abnormalities have also been described. Mortality at or shortly after birth has also been reported. Two reliable forms of contraception or abstinence must be used for at least 4 weeks before initiating therapy, during therapy, and for 4 weeks following discontinuation of thalidomide for women of childbearing potential.  A negative pregnancy test (sensitivity of at least 50 mIU/mL) within 24 hours prior to beginning therapy, weekly during the first 4 weeks, and every 4 weeks (every 2 weeks for women with irregular menstrual cycles) thereafter is required. Males (even those vasectomized) must use a latex condom during any sexual contact with women of childbearing age. Risk to the fetus from semen of male patients is unknown. Thalidomide must be immediately discontinued and the patient referred to a reproductive toxicity specialist if pregnancy occurs during treatment. Any suspected fetal exposure to thalidomide must be reported to the FDA via the MedWatch program (800) FDA-1088 and to Celgene Corporation (888) 423-5436.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Use in multiple myeloma patients results in an increased risk of thrombotic events such as deep vein thrombosis and pulmonary embolism",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Risk significantly increases when used in combination with standard chemotherapeutic agents, including dexamethasone. Monitor for signs and symptoms of thromboembolism; some patients at risk may benefit from prophylactic anticoagulation or aspirin therapy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Frequently causes drowsiness and somnolence. Patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). May cause peripheral neuropathy which may be irreversible; usually associated with chronic use, but has been seen following short-term therapy; no correlation with cumulative dose identified in adults. In children,  significant correlations with cumulative dose (&gt;20 g) and duration of therapy (&gt;10 months) have been reported (Priolo, 2008). Patients should be monitored for signs and symptoms of peripheral neuropathy; consider immediate discontinuation (if clinically appropriate) in patients who develop neuropathy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause dizziness and orthostatic hypotension. May cause neutropenia; discontinue therapy if absolute neutrophil count decreases to &lt;750/mm",
"     <sup>",
"      3",
"     </sup>",
"     . Increase HIV viral load has been reported in clinical trials; clinical significance is unknown.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Thalidomide should only be prescribed under the restricted  S.T.E.P.S.&reg; program",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Thalidomide should only be prescribed to patients (male and female) who can understand and comply with the conditions of the S.T.E.P.S.&reg; program. Distribution is restricted; if the patient is 12-18 years of age, a parent or legal guardian must be able to understand and ensure compliance with the S.T.E.P.S.&reg; program; physicians, pharmacists, and patients must be registered with the S.T.E.P.S.&reg; program.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F226450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abatacept: Anti-TNF Agents may enhance the adverse/toxic effect of Abatacept. An increased risk of serious infection during concomitant use has been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anakinra: Anti-TNF Agents may enhance the adverse/toxic effect of Anakinra. An increased risk of serious infection during concomitant use has been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Canakinumab: Anti-TNF Agents may enhance the adverse/toxic effect of Canakinumab. Specifically, the risk for serious infections and/or neutropenia may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Certolizumab Pegol: Anti-TNF Agents may enhance the immunosuppressive effect of Certolizumab Pegol.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexamethasone (Systemic): May enhance the dermatologic adverse effect of Thalidomide. Dexamethasone (Systemic) may enhance the thrombogenic effect of Thalidomide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pamidronate: Thalidomide may enhance the nephrotoxic effect of Pamidronate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rilonacept: Anti-TNF Agents may enhance the adverse/toxic effect of Rilonacept.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May enhance the immunosuppressive effect of Anti-TNF Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Anti-TNF Agents may enhance the adverse/toxic effect of Tofacitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zoledronic Acid: Thalidomide may enhance the adverse/toxic effect of Zoledronic Acid.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F226452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F226466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      [U.S. Boxed Warning]: Thalidomide may cause severe birth defects or embryo-fetal death if taken during pregnancy. Thalidomide cannot be used in women who are pregnant or may become pregnant during therapy as even a single dose may cause birth defects. In order to decrease the risk of fetal exposure, thalidomide is available only through a special restricted distribution program (Thalomid REMS&trade;).",
"     </b>",
"     Reproduction studies in animals and data from pregnant women have shown evidence of fetal abnormalities; use is contraindicated in women who are or may become pregnant. Anomalies observed in humans include amelia, phocomelia, bone defects, ear and eye abnormalities, facial palsy, congenital heart defects, urinary and genital tract malformations; mortality in ~40% of infants at or shortly after birth has also been reported.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;display:inline\">",
"     Women of reproductive potential must avoid pregnancy 4 weeks prior to therapy, during therapy, during therapy interruptions, and for &ge;4 weeks after therapy is discontinued.  Two forms of effective contraception or total abstinence from heterosexual intercourse must be used by females who are not infertile or who have not had a hysterectomy.  A negative pregnancy test (sensitivity of at least 50 mIU/mL) 10-14 days prior to therapy, within 24 hours prior to beginning therapy, weekly during the first 4 weeks, and every 4 weeks (every 2 weeks for women with irregular menstrual cycles) thereafter is required for women of childbearing potential. Thalidomide must be immediately discontinued for a missed period, abnormal pregnancy test or abnormal menstrual bleeding; refer patient to a reproductive toxicity specialist if pregnancy occurs during treatment.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;display:inline\">",
"     Females of reproductive potential must also avoid contact with thalidomide capsules.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;display:inline\">",
"     Thalidomide is also present in the semen of males. Males (even those vasectomized) must use a latex or synthetic condom during any sexual contact with women of childbearing potential and for up to 28 days following discontinuation of therapy. Males taking thalidomide must not donate sperm.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;display:inline\">",
"     The parent or legal guardian for patients between 12-18 years of age must agree to ensure compliance with the required guidelines.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;display:inline\">",
"     If pregnancy occurs during treatment, thalidomide must be immediately discontinued and the patient referred to a reproductive toxicity specialist. Any suspected fetal exposure to thalidomide must be reported to the FDA via the MedWatch program (1-800-FDA-1088) and to Celgene Corporation (1-888-423-5436). In Canada, thalidomide is available only through a restricted-distribution program called RevAid&reg; (1-888-738-2431).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1038584\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for signs and symptoms of thromboembolism (shortness of breath, chest pain, arm/leg swelling). CBC with differential, platelets. Pregnancy testing (sensitivity of at least 50 mIU/mL) is required within 24 hours prior to initiation of therapy, weekly during the first 4 weeks, then every 4 weeks in women with regular menstrual cycles or every 2 weeks in women with irregular menstrual cycles. Signs of neuropathy monthly for the first 3 months, then periodically during treatment; consider monitoring of sensory nerve application potential amplitudes (at baseline and every 6 months) to detect asymptomatic neuropathy. In HIV-seropositive patients: Viral load after 1 and 3 months, then every 3 months.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1038568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     One study suggests that therapeutic plasma thalidomide concentrations in graft-vs-host reactions are 5-8 mcg/mL 2 hours postdose (Vogelsang, 1992).",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1038566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The exact mechanism of action is unknown. Thalidomide has immunomodulatory, anti-inflammatory, and antiangiogenic characteristics; may suppress excessive tumor necrosis factor-alpha production in patients with ENL, yet may increase plasma tumor necrosis factor-alpha levels in HIV-positive patients.  In multiple myeloma, thalidomide is associated with an increase in natural killer cells and increased levels of interleukin-2 and interferon gamma. Other proposed mechanisms of action include suppression of angiogenesis, prevention of free-radical-mediated DNA damage, increased cell mediated cytotoxic effects, and altered expression of cellular.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1038569\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 70-120 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 55% to 66%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Nonenzymatic hydrolysis in plasma; forms multiple metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 5-7 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: 3-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (&lt;1% as unchanged drug)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1038588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/48/44805?source=see_link\">",
"      see \"Thalidomide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Birth defects may occur; oral and written instructions about the necessity of using two methods of contraception and the necessity of keeping return visits for pregnancy testing will be provided. Do not donate blood or sperm (male patients) while taking this medicine. Avoid extensive handling of capsules; capsules should remain in blister pack until ingestion. If exposed to the powder content from broken capsules or body fluids from patients receiving thalidomide, the exposed area should be washed with soap and water. Avoid alcohol. May experience sleepiness; dizziness; fatigue; fever; headaches; lack of concentration (use caution when driving, climbing stairs, or engaging in tasks requiring alertness until response to drug is known); nausea or vomiting; constipation or diarrhea; or dry mouth. Report any of the above if persistent or severe. Report chest pain or palpitations or swelling of extremities; respiratory difficulty; back, neck, muscle pain, muscle weakness, or stiffness; numbness or pain in extremities; significant weight loss or gain; skin rash or eruptions; increased nervousness, anxiety, confusion, or insomnia; or any other symptom of adverse reactions. For missed doses, if &lt;12 hours have passed, patient may receive dose; if &gt;12 hours have passed, wait until next dose is due.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F7710743\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thalidomide-associated birth defects have only been reported as a result of direct oral ingestion of drug; data is not available regarding cutaneous absorption or inhalation exposures and whether these exposures may result in birth defects.",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F13791503\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent: Use appropriate precautions for handling and disposal.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     A 20 mg/mL oral suspension may be prepared with capsules and a 1:1 mixture of Ora-Sweet&reg; and Ora-Plus&reg;. Empty the contents of twelve 100 mg capsules into a glass mortar.  Add small portions of the vehicle and mix to a uniform paste; mix while adding the vehicle in incremental proportions to almost 60 mL; transfer to an amber calibrated bottle, rinse mortar with vehicle, and add quantity of vehicle sufficient to make 60 mL. Label &ldquo;shake well,&rdquo;  &ldquo;protect from light,&rdquo; and &ldquo;refrigerate&rdquo;. Stable for 35 days refrigerated.",
"    </p>",
"    <div class=\"reference\">",
"     Kraft S, Johnson CE, and Tyler RP, \"Stability of an Extemporaneously Prepared Thalidomide Suspension,\"",
"     <i>",
"      Am J Health Syst Pharm",
"     </i>",
"     , 2011, 69(1):56-8.",
"     <span class=\"pubmed-id\">",
"      22180553",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bessmertny O and Pham T, \"Thalidomide Use in Pediatric Patients,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2002, 36(3):521-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/11895068/pubmed\" id=\"11895068\" target=\"_blank\">",
"        11895068",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Britton WJ and Lockwood DN, \"Leprosy,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2004, 363(9416):1209-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/15081655/pubmed\" id=\"15081655\" target=\"_blank\">",
"        15081655",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Browne PV, Weisdorf DJ, DeFor T, et al, \"Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2000, 26(8):865-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/11081386/pubmed\" id=\"11081386\" target=\"_blank\">",
"        11081386",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ehrenpreis ED, Kane SV, Cohen LB, et al, \"Thalidomide Therapy for Patients With Refractory Crohn's Disease: An Open-Label Trial,\"",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1999, 117(6):1271-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/10579967/pubmed\" id=\"10579967\" target=\"_blank\">",
"        10579967",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eriksson T, H&ouml;glund P, Turesson I, et al, \"Pharmacokinetics of Thalidomide in Patients With Impaired Renal Function and While On and Off Dialysis,\"",
"      <i>",
"       J Pharm Pharmacol",
"      </i>",
"      , 2003, 55(12):1701-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/14738599/pubmed\" id=\"14738599\" target=\"_blank\">",
"        14738599",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Facchini S, Candusso M, Martelossi S, et al, \"Efficacy of Long-Term Treatment With Thalidomide in Children and Young Adults With Crohn Disease: Preliminary Results,\"",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 2001, 32(2):178-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/11321389/pubmed\" id=\"11321389\" target=\"_blank\">",
"        11321389",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Facon T, Mary JY, Hulin C, et al, \"Melphalan and Prednisone Plus Thalidomide Versus Melphalan and Prednisone Alone or Reduced-Intensity Autologous Stem Cell Transplantation in Elderly Patients With Multiple Myeloma (IFM 99-06): A Randomised Trial,\"",
"      <i>",
"       Lancet",
"      </i>",
"      , 2007, 370(9594):1209-18.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/17920916/pubmed\" id=\"17920916\" target=\"_blank\">",
"        17920916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacobson JM, Greenspan JS, Spritzler J, et al, &ldquo;Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients With Human Immunodeficiency Virus Infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1997, 336(21):1487-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/9154767/pubmed\" id=\"9154767\" target=\"_blank\">",
"        9154767",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kulkarni S, Powles R, Sirohi B, et al, \"Thalidomide After Allogeneic Haematopoietic Stem Cell Transplantation: Activity in Chronic But Not in Acute Graft-Versus-Host Disease,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2003, 32(2):165-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/12838281/pubmed\" id=\"12838281\" target=\"_blank\">",
"        12838281",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lazzerini M, Martelossi S, Marchetti F, et al, \"Efficacy and Safety of Thalidomide in Children and Young Adults With Intractable Inflammatory Bowel Disease: Long-Term Results,\"",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 2007, 25(4):419-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/17269997/pubmed\" id=\"17269997\" target=\"_blank\">",
"        17269997",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lehman TJ, Schechter SJ, Sundel RP, et al, \"Thalidomide for Severe Systemic Onset Juvenile Rheumatoid Arthritis: A Multicenter Study,\"",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2004, 145(6):856-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/15580219/pubmed\" id=\"15580219\" target=\"_blank\">",
"        15580219",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Martelossi S, Marchetti F, Lenhard A, et al, \"Treatment With Thalidomide in Children and Adolescents With Inflammatory Bowel Disease,\"",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 2004, 39(1):S282-3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Matthews SJ and McCoy C, \"Thalidomide: A Review of Approved and Investigational Uses,\"",
"      <i>",
"       Clin Ther",
"      </i>",
"      , 2003, 25(2):342-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/12749503/pubmed\" id=\"12749503\" target=\"_blank\">",
"        12749503",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mehta P, Kedar A, Graham-Pole J, et al, \"Thalidomide in Children Undergoing Bone Marrow Transplantation: Series at a Single Institution and Review of the Literature,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1999, 103(4):e44.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/10103336/pubmed\" id=\"10103336\" target=\"_blank\">",
"        10103336",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Okafor MC, \"Thalidomide for Erythema Nodosum Leprosum and Other Applications,\"",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2003, 23(4):481-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/12680478/pubmed\" id=\"12680478\" target=\"_blank\">",
"        12680478",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Palumbo A, Rajkumar SV, Dimopoulos MA, et al, \"Prevention of Thalidomide- and Lenalidomide-Associated Thrombosis in Myeloma,\"",
"      <i>",
"       Leukemia",
"      </i>",
"      , 2008, 22(2):414-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/18094721/pubmed\" id=\"18094721\" target=\"_blank\">",
"        18094721",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Parker PM, Chao N, Nademanee A, et al, \"Thalidomide as Salvage Therapy for Chronic Graft-Versus-Host Disease,\"",
"      <i>",
"       Blood",
"      </i>",
"      , 1995, 86(9):3604-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/7579470/pubmed\" id=\"7579470\" target=\"_blank\">",
"        7579470",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Priolo T, Lamba LD, Giribaldi G, et al, \"Childhood Thalidomide Neuropathy: A Clinical and Neurophysiologic Study,\"",
"      <i>",
"       Pediatr Neurol",
"      </i>",
"      , 2008, 38(3):196-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/18279755/pubmed\" id=\"18279755\" target=\"_blank\">",
"        18279755",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rovelli A, Arrigo C, Nesi F, et al, \"The Role of Thalidomide in the Treatment of Refractory Chronic Graft-Versus-Host Disease Following Bone Marrow Transplantation in Children,\"",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 1998, 21(6):577-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/9543061/pubmed\" id=\"9543061\" target=\"_blank\">",
"        9543061",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seol Y, Chung J, Kwon B, et al, &ldquo;Treatment for Patients With Multiple Myeloma Complicated by Renal Failure by Thalidomide-Based Regimens,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2010, 28(Suppl):e13093 [Abstract e13093 From 2010 ASCO Annual Meeting].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Teo SK, Colburn WA, Tracewell WG, et al, \"Clinical Pharmacokinetics of Thalidomide,\"",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 2004, 43(5):311-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/15080764 /pubmed\" id=\"15080764 \" target=\"_blank\">",
"        15080764",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Thompson JL and Hansen LA, \"Thalidomide Dosing in Patients With Relapsed or Refractory Multiple Myeloma,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2003, 37(4):571-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/12659617/pubmed\" id=\"12659617\" target=\"_blank\">",
"        12659617",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tosi P, Zamagni E, Tacchetti P, et al, &ldquo;Thalidomide-Dexamethasone as Induction Therapy Prior to Autologous Stem-Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma and Renal Failure,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 2009, 114(22):4934 [Abstract 4934 From 2009 ASH Annual Meeting].",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vasiliauskas EA, Kam LY, Abreu-Martin MT, et al, \"An Open-Label Pilot Study of Low-Dose Thalidomide in Chronically Active, Steroid-Dependent Crohn's Disease,\"",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1999, 117(6):1278-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/10579968/pubmed\" id=\"10579968\" target=\"_blank\">",
"        10579968",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Vogelsang GB, Farmer ER, Hess AD, et al, \"Thalidomide for the Treatment of Chronic Graft-Versus-Host Disease,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1992, 326(16):1055-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/1549151/pubmed\" id=\"1549151\" target=\"_blank\">",
"        1549151",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wolff D, Schleuning M, von Harsdorf S, et al, \"Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-Versus-Host Disease,\"",
"      <i>",
"       Biol Blood Marrow Transplant",
"      </i>",
"      , 2011, 17(1):1-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/20685255/pubmed\" id=\"20685255\" target=\"_blank\">",
"        20685255",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zheng CF, Xu JH, Huang Y, et al, \"Treatment of Pediatric Refractory Crohn's Disease With Thalidomide,\"",
"      <i>",
"       World J Gastroenterol",
"      </i>",
"      , 2011, 17(10):1286-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?41/42/42664/abstract-text/21455327/pubmed\" id=\"21455327\" target=\"_blank\">",
"        21455327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13090 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-61.234.146.186-FE4A772EBF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42664=[""].join("\n");
var outline_f41_42_42664=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708930\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226481\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226482\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038544\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038576\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226457\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226442\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234348\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10523386\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038582\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038564\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038545\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226506\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226505\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038552\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7710704\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038553\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300130\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226450\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226452\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F226466\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038584\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038568\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038566\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038569\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1038588\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7710743\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13791503\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13090\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13090|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?28/62/29673?source=related_link\">",
"      Thalidomide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/48/44805?source=related_link\">",
"      Thalidomide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_42_42665="Complications of diagnostic cardiac catheterization";
var content_f41_42_42665=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Complications of diagnostic cardiac catheterization",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Joseph P Carrozza, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Donald Cutlip, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/42/42665/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/42/42665/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Throughout the 1960s and 1970s, cardiac catheterization was primarily a diagnostic procedure that was used to evaluate hemodynamics, ventricular function, and coronary anatomy. However, the introduction of improved angioplasty equipment and new interventional devices in the 1980s made catheterization an important tool in the treatment of cardiovascular disease.",
"   </p>",
"   <p>",
"    Although diagnostic catheterization and percutaneous coronary intervention (PCI) are done by skin puncture rather than incision, and under local rather than general anesthesia, they can cause a variety of adverse events, ranging from minor problems without long-term sequelae to major complications requiring immediate corrective action. Furthermore, newer interventional procedures may be associated with different and, in some cases, more frequent complications.",
"   </p>",
"   <p>",
"    The most common complications associated with diagnostic cardiac catheterization will be reviewed here. The complications associated with cardiac catheterization involving PCI are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38666?source=see_link\">",
"     \"Periprocedural complications of percutaneous coronary intervention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MAJOR COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of producing a major complication (death, myocardial infarction, or major embolization) during diagnostic cardiac catheterization is generally well below 1 percent. As a result, the risk-to-benefit ratio still favors performing this procedure as a part of the evaluation of potentially fatal or lifestyle-limiting cardiac disease.",
"   </p>",
"   <p>",
"    For the individual patient, the risk of an adverse event is dependent upon demographics, cardiovascular anatomy, clinical circumstances including comorbidities, the experience of the operator, and the type of procedure being performed (",
"    <a class=\"graphic graphic_table graphicRef60388 graphicRef51490 graphicRef54367 \" href=\"mobipreview.htm?37/26/38317\">",
"     table 1A-C",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"     1",
"    </a>",
"    ]. Severe peripheral artery disease is a risk factor for all of the major complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Death following diagnostic cardiac catheterization is now rare. Compared with the 1 percent mortality rate seen in the 1960s, the second registry of the Society for Cardiac Angiography revealed that the procedural mortality had fallen to 0.1 percent in the more than 200,000 patients catheterized between 1984 and 1987 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-risk subgroups have been identified in multiple large series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1-9\">",
"     1-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age above 60 years and below one year and women have an increased mortality rate after catheterization.",
"     </li>",
"     <li>",
"      New York Heart Association functional class IV is associated with an almost tenfold increase in mortality compared with classes I and II (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A similar increase in risk is seen with severe disease of the left main coronary artery (compared to single vessel disease) and with a left ventricular ejection fraction (LVEF) below 30 percent (compared to an LVEF above 50 percent).",
"     </li>",
"     <li>",
"      Patients with valvular heart disease, chronic kidney disease, diabetes mellitus requiring insulin therapy, peripheral artery disease, cerebrovascular disease, and pulmonary insufficiency all appear to have an increased incidence of death and major complications from cardiac catheterization. Mortality is especially high in those with preexisting renal insufficiency who have further deterioration of renal function within 48 hours after the procedure, particularly when dialysis is required [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Acute renal failure'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Myocardial infarction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although periprocedural myocardial ischemia is fairly common, infarction is rare. The general risk of myocardial infarction (MI) in most series is less than 0.1 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. However, the risk of precipitating an MI in an individual patient is influenced by patient-related and technique-related factors. Risk factors that predispose patients to MI during the procedure include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The extent of disease (0.17 percent with left main coronary disease versus 0.06 percent in single vessel disease) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Recent non-ST elevation acute coronary syndrome.",
"     </li>",
"     <li>",
"      Diabetes mellitus requiring insulin therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Stroke and transient ischemic attack",
"    </span>",
"    &nbsp;&mdash;&nbsp;A stroke is a rare but potentially devastating complication of cardiac catheterization. The incidence of stroke was 0.07 to 0.10 percent in an analysis of two large databases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2,11\">",
"     2,11",
"    </a>",
"    ] and has more recently been reported to be as high as 0.2 to 0.4 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/12\">",
"     12",
"    </a>",
"    ]. Risk factors for stroke include the severity of coronary artery disease, the length of fluoroscopy time, diabetes, hypertension, prior stroke, or renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stroke and transient ischemic attacks are thought to be caused by disruption of atheromatous plaques on the walls of the aorta. The risk of intracerebral hemorrhage is increased in those receiving anticoagulation or thrombolytic therapy as well as with any of the following: age &ge;75 years; female sex; systolic blood pressure &ge;160 mmHg; black race; and low body weight (",
"    <a class=\"graphic graphic_table graphicRef62946 \" href=\"mobipreview.htm?42/52/43851\">",
"     table 3",
"    </a>",
"    ). Based on the number of the risk factors present, the rate of intracerebral hemorrhage varies from less than 1 percent to more than 4 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/43/1721?source=see_link&amp;anchor=H69243091#H69243091\">",
"     \"Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy\", section on 'Stroke'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Meticulous attention to technical factors such as wire and catheter exchanges is mandatory in all patients, regardless of risk. Transient neurologic deficits may also result from the injection of high osmolar contrast agents into the carotid or vertebral arteries.",
"   </p>",
"   <p>",
"    The majority of patients with a periprocedural stroke have an unfavorable neurologic outcome and, in one study, the in-hospital mortality was 32 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Role of valvular aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of stroke may be particularly high in patients with valvular aortic stenosis (AS) who undergo retrograde catheterization of the aortic valve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. This was demonstrated in a study of 152 patients with severe AS (mean age 71 years) who were randomly assigned to cardiac catheterization with or without catheter passage through the valve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/13\">",
"     13",
"    </a>",
"    ]. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cranial MRI done before and after the catheterization demonstrated focal lesions consistent with cerebral emboli in 22 percent of those who underwent retrograde catheterization of the aortic valve, but in none of the patients who did not.",
"     </li>",
"     <li>",
"      Detailed neurologic examination done before and after the catheterization demonstrated clinically apparent deficits in 3 percent of those who underwent retrograde catheterization, but in none of the other patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, retrograde catheterization should be performed with",
"    <strong>",
"     caution",
"    </strong>",
"    in patients with severe calcific AS and only when the information sought cannot be reliably obtained noninvasively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Asymptomatic embolic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the incidence of stroke after cardiac catheterization was 0.07 to 0.10 percent in an analysis of two large databases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2,11\">",
"     2,11",
"    </a>",
"    ]. However, asymptomatic embolic events are much more common [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/13,15,16\">",
"     13,15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was illustrated in a prospective study of 48 patients (mean age 62 years) who underwent cardiac catheterization and angiography and, in some patients, percutaneous coronary intervention; magnetic resonance imaging (MRI) was performed before and about 24 hours after the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/15\">",
"     15",
"    </a>",
"    ]. There were no embolic lesions on diffusion-weighted imaging at baseline, but seven patients (15 percent) had nine cerebral infarcts after the procedure; all were asymptomatic.",
"   </p>",
"   <p>",
"    Similar findings were noted in a report of 47 unselected patients in whom transcranial Doppler was used to detect microemboli and MRI to detect new lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/16\">",
"     16",
"    </a>",
"    ]. The median number of solid (ie, not gaseous) microemboli was significantly higher with a transradial compared to a transfemoral access (57 versus 36). New MRI lesions occurred in 5 of 33 patients (15 percent) after transradial catheterization, compared to none of nine after transfemoral catheterization. Most of the patients with new lesions remained asymptomatic.",
"   </p>",
"   <p>",
"    These observations suggest that catheter manipulation in the diseased aortic root releases small pieces of atherosclerotic debris more commonly than suspected, based upon the fortunately low incidence of clinically apparent stroke. The same principles presumably apply to peripheral embolism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LOCAL VASCULAR COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local complications at the site of catheter insertion are among the most common problems seen after cardiac catheterization. These problems may include acute thrombosis, distal embolization, dissection or poorly controlled bleeding (which may be manifested as free hemorrhage or contained hematoma in the femoral or retroperitoneal areas), pseudoaneurysm, or arteriovenous fistula. Hemorrhage and hematoma are usually evident within 12 hours after the procedure by virtue of local discomfort, hypotension, or falling hematocrit, which lead to confirmatory noninvasive testing (ultrasound or CT). In contrast, other complications such as pseudoaneurysm and arteriovenous fistula may not become apparent for days to weeks afterward.",
"   </p>",
"   <p>",
"    The vascular complications associated with percutaneous coronary intervention are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38666?source=see_link\">",
"     \"Periprocedural complications of percutaneous coronary intervention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hemostasis at the access site",
"    </span>",
"    &nbsp;&mdash;&nbsp;The traditional approach to catheter removal at the conclusion of cardiac catheterization was local hand-applied pressure for 15 to 30 minutes. Two alternative approaches are available: mechanical clamp compression and, more importantly, arterial puncture closing devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H678090977\">",
"    <span class=\"h3\">",
"     Mechanical clamp",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical clamp compression reduces the amount of staff time and effort required to assure hemostasis, and may reduce the rate of vascular complications. One trial randomly assigned 778 patients to hand applied pressure or mechanical clamp pressure; the latter reduced the frequency of ultrasound-defined femoral vascular complications (femoral artery thrombosis, echogenic hematoma, pseudoaneurysm, or arteriovenous fistulae formation) by 63 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/17\">",
"     17",
"    </a>",
"    ]. However, clamping does not decrease the importance of having staff in attendance to ensure that the device is placed and remains in the correct position.",
"   </p>",
"   <p>",
"    The circumstances which may make mechanical clamps the preferred method of achieving hemostasis include procedures where longer hemostasis time is anticipated: larger sheaths, excessively anticoagulated patients, recognized hematoma, and dual antiplatelet therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H678090984\">",
"    <span class=\"h3\">",
"     Closure devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial puncture closing devices (APCDs) eliminate the need for prolonged arterial compression and reduce the subsequent interval of bed rest that is otherwise required. Two types of APCDs in clinical use include collagen hemostatic puncture closure devices (",
"    <a class=\"graphic graphic_figure graphicRef61621 \" href=\"mobipreview.htm?13/50/14127\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/18-21\">",
"     18-21",
"    </a>",
"    ] and suture-mediated devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    APCDs may increase the risk of local vascular complications. In a meta-analysis of 30 trials including 4000 patients who underwent coronary angiography or PCI, nonsignificant increases in the incidence of groin hematoma, bleeding, and pseudoaneurysm formation were associated with use of these devices compared to manual compression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/23\">",
"     23",
"    </a>",
"    ]. When only those trials with an intention-to-treat analysis were included, the relative risks of groin hematoma and pseudoaneurysm formation were significantly increased (1.89 and 5.40, respectively).",
"   </p>",
"   <p>",
"    A larger meta-analysis that included 30 studies involving 37,066 patients concluded that the risk of complications depended upon the specific device used and whether the procedure was a diagnostic catheterization or a PCI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/24\">",
"     24",
"    </a>",
"    ]. In the overall analysis, there was a significant increase in risk with an APCD (odds ratio [OR] 1.34, 95% CI 1.01-1.79).",
"   </p>",
"   <p>",
"    For reports limited to diagnostic studies, there were no significant differences between APCDs and mechanical compression, although there were trends toward fewer complications with the AngioSeal device (OR 0.71) and toward more complications with the VasoSeal and Perclose devices (OR 1.85 and 1.51, respectively).",
"   </p>",
"   <p>",
"    For reports limited to PCI, there were no significant differences between APCDs and mechanical compression overall. However, there was a significant increase in vascular complications with the VasoSeal device (OR 2.52).",
"   </p>",
"   <p>",
"    Closure devices also increase the risk of local infection or endarteritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Although this complication is infrequent (0.3 percent in one series) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/26\">",
"     26",
"    </a>",
"    ], it can be serious when it occurs. Consideration should be given to periprocedural antibiotics in immunocompromised patients following prolonged arterial access or when sterility has been breached when a closure device is used. It may also be prudent for the operator to change gloves prior to using an arterial closure device. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Infection'",
"    </a>",
"    below.) An angiogram of the femoral artery should be performed prior to use of an APCD. Use of closure devices should be avoided if a hematoma has formed during the procedure, or in the presence of severe iliofemoral vascular disease, and when the access site is below the bifurcation of the superficial and profunda femoral arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Prior warfarin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients who are being treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , the optimal approach is to withhold warfarin and wait until the INR reaches 1.5 before proceeding with catheterization. When the procedure cannot be delayed, it has been suggested that, in patients with an INR of 2.0 to 3.0, manual pressure hemostasis may be sufficient to prevent excess bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/27\">",
"     27",
"    </a>",
"    ]. In patients with an INR &gt;3.0, administration of fresh frozen plasma prior to arterial sheath removal may be warranted. The transradial approach may also be useful in such cases.",
"   </p>",
"   <p>",
"    The risk of local bleeding in",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    -treated patients is likely to be greater in those undergoing PCI who are often treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    , and a glycoprotein",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitor. These patients typically have longer intraarterial times and more manipulation of the arterial access site. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27786?source=see_link\">",
"     \"Antithrombotic therapy for percutaneous coronary intervention: General use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hematoma formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematoma formation is not uncommon in the soft tissue of the upper thigh and the patient should be advised that the development of a large area of ecchymosis is likely. Although most resolve over a period of days, femoral nerve compression can occur, which may take weeks to months to resolve. Patients should be advised to avoid strenuous activity or lifting heavy objects within the first week following arterial catheterization. Surgical repair for a hematoma is generally not required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Retroperitoneal extension",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the arterial puncture occurs above the inguinal ligament, a hematoma may extend into the retroperitoneal space, causing hypotension and ipsilateral flank pain. CT scanning or abdominal ultrasonography can help to establish the diagnosis. Treatment is usually conservative, consisting of bed rest and blood transfusion rather than surgical correction. Reversal of systemic anticoagulation may be indicated if bleeding persists or is associated with hemodynamic compromise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Arteriovenous fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ongoing bleeding from the arterial puncture site may decompress into the adjacent venous puncture site, leading to the formation of an arteriovenous fistula. This complication may be recognized by the presence of a thrill or continuous bruit at the site of catheter insertion.",
"   </p>",
"   <p>",
"    Surgical repair is usually necessary, since fistulae tend to enlarge over time. The most common finding at surgery is a puncture site below the common femoral artery, which illustrates the importance of careful technique in avoiding this complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Pseudoaneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a hematoma remains in continuity with the arterial lumen, a pseudoaneurysm may develop with blood flow into and out of the hematoma cavity during systole and diastole. A pseudoaneurysm is most often recognized by the presence of a pulsatile mass with a systolic bruit over the catheter insertion site; it can be confirmed by duplex ultrasonography. Almost all pseudoaneurysms occur within the first three days after removal of the arterial sheath, and most of the remaining cases by seven days after sheath removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The main risk factor for pseudoaneurysm formation is an inadequate period of manual compression. This was illustrated in a series of 581 angiographic procedures involving transfemoral arterial catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/29\">",
"     29",
"    </a>",
"    ]. A pseudoaneurysm occurred in 14 percent of the first 300 procedures in which standard manual compression was performed, compared to 1.1 percent of the next 281 procedures when manual compression was continued for at least five minutes after local bleeding had stopped.",
"   </p>",
"   <p>",
"    Other risk factors include large bore sheaths, postprocedural anticoagulation, antiplatelet therapy during the intervention, age &gt;65 years, obesity, hypertension, peripheral artery disease, hemodialysis, cannulation of the superficial rather than common femoral artery, and complex interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical management should be performed when a pseudoaneurysm occurs at the site of a vascular anastomosis, becomes very large and threatens or causes skin necrosis, is expanding rapidly, occurs spontaneously, as it may be infected, or there is a failure of a minimally invasive procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/30\">",
"     30",
"    </a>",
"    ]. Expanding hematomas have a propensity towards eventual rupture, especially if the patient is maintained on anticoagulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1,7,31,32\">",
"     1,7,31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment of smaller pseudoaneurysms may be accomplished with either direct ultrasound-guided compression or with ultrasound-guided local injection of thrombin or collagen into the pseudoaneurysm cavity, which has a higher success rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/28,33-35\">",
"     28,33-35",
"    </a>",
"    ]. Although an effective approach, ultrasound-guided compression is uncomfortable for both the patient and the person applying compression.",
"   </p>",
"   <p>",
"    The success rate of ultrasound-guided injection of bovine thrombin was illustrated in a series of 240 patients with simple or complex pseudoaneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/28\">",
"     28",
"    </a>",
"    ]. The primary success rate was 96 percent with simple pseudoaneurysms and 89 percent with complex pseudoaneurysms. The secondary success rate was 99.6 percent (all but one patient). The authors also reviewed 34 studies with 1388 patients; the overall success rate was 97.2 percent.",
"   </p>",
"   <p>",
"    The high success rate of ultrasound-guided injection has made it the treatment of choice for most postcatheterization pseudoaneurysms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/30\">",
"     30",
"    </a>",
"    ]. However, the procedure should not be performed when, as defined above, there is an indication for surgical management.",
"   </p>",
"   <p>",
"    In rare cases, pseudoaneurysms less than 2 cm can be managed conservatively and monitored by serial imaging to confirm spontaneous resolution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Arterial thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial thrombosis is rare and occurs slightly more often when the brachial approach is used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Predisposing factors to femoral artery thrombosis include small vessel lumen, peripheral artery disease, diabetes mellitus, female sex, placement of a large diameter catheter or sheath (eg, intraaortic balloon pump), or a long catheter dwell time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2-7,31,32\">",
"     2-7,31,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with lower extremity pain or paresthesia, plus reduced or absent distal pulses not responding to catheter removal, should be evaluated for possible flow obstructing thrombus or dissection. Urgent vascular surgery or thrombectomy may be required for preservation of the limb.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Radial artery access",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local vascular complications appear to occur less frequently with radial artery access. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38666?source=see_link&amp;anchor=H23#H23\">",
"     \"Periprocedural complications of percutaneous coronary intervention\", section on 'Vascular complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Is the palmar arch intact?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radial artery cannulation is associated with a 5 to 19 percent chance of radial artery occlusion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/36\">",
"     36",
"    </a>",
"    ]. This complication is not clinically important in most patients because the hand is perfused by both the radial and ulnar arteries with extensive collateral flow between the two. However, some patients have incomplete palmar arches, which may diminish collateral perfusion, possibly leading to hand ischemia in the presence of radial artery occlusion (",
"    <a class=\"graphic graphic_figure graphicRef55221 \" href=\"mobipreview.htm?10/1/10260\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The modified Allen test has traditionally been used to identify patients at increased risk from radial artery catheterization. However, many centers now use pulse oximetry and plethysmography.",
"   </p>",
"   <p>",
"    The modified Allen test, originally developed to evaluate patients with thromboangiitis obliterans, assesses the adequacy of collateral blood supply from the ulnar artery to the hand via the palmar arches (",
"    <a class=\"graphic graphic_figure graphicRef55221 \" href=\"mobipreview.htm?10/1/10260\">",
"     figure 2",
"    </a>",
"    ). The test consists of the following steps (",
"    <a class=\"graphic graphic_figure graphicRef70306 \" href=\"mobipreview.htm?3/61/4049\">",
"     figure 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient's hand is initially held high while the fist is clenched and both radial and ulnar arteries are compressed; this allows the blood to drain from the hand.",
"     </li>",
"     <li>",
"      The hand is then lowered and the fist is opened.",
"     </li>",
"     <li>",
"      After pressure is released over the ulnar artery, color should return to the hand within six seconds, indicating a patent ulnar artery and an intact superficial palmar arch. The test is considered abnormal if 10 seconds or more is required for color to return.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In two large series of patients undergoing cardiac catheterization, an abnormal Allen test result was obtained in 6 and 27 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The importance of an abnormal test was evaluated in a study of 55 patients undergoing coronary angiography, 20 of whom had an abnormal test [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/36\">",
"     36",
"    </a>",
"    ]. After 30 minutes of subsequent radial artery occlusion, the patients with an abnormal test had significantly reduced blood flow to the thumb and an elevated thumb capillary lactate.",
"   </p>",
"   <p>",
"    Based upon such observations, radial artery catheterization is usually not performed in patients with an abnormal modified Allen test. A possible exception occurs in patients with an excessive estimated risk from a femoral approach (eg, severe peripheral artery disease, large abdominal aortic aneurysm, morbid obesity) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The results of the modified Allen test can be altered by a number of factors, including overextension of the wrist, skin tension over the ulnar artery, and operator error. As a result, an appreciable number of false positive and false negative results have been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/37\">",
"     37",
"    </a>",
"    ]. As an alternative, many centers use a more direct assessment of blood flow to the thumb during radial artery occlusion, which can be accomplished with pulse oximetry and plethysmography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/37,39\">",
"     37,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The traditional modified Allen test was compared to pulse oximetry and plethysmography in a consecutive series of 1010 patients referred for diagnostic cardiac catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/37\">",
"     37",
"    </a>",
"    ]. The modified Allen test was considered abnormal if palmar blanching persisted for &ge;10 seconds after release of ulnar compression. Plethysmography was observed for two minutes during radial artery compression. Plethysmography was characterized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A &mdash; no change in the amplitude of the pulse tracing during compression",
"     </li>",
"     <li>",
"      B &mdash; reduction in amplitude with compression",
"     </li>",
"     <li>",
"      C &mdash; loss of pulse tracing with initial compression, but recovery of flow during two minutes of compression (signifying development of collateral flow)",
"     </li>",
"     <li>",
"      D &mdash; loss of pulse tracing with no recovery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients in categories A, B and C were considered to have a patent ulnopalmar arch, and therefore eligible for radial catheterization.",
"   </p>",
"   <p>",
"    The modified Allen test was abnormal in significantly more patients than plethysmography (6.3 versus 1.5 percent). The authors concluded that plethysmography more accurately demonstrates the adequacy of the ulnopalmar arch, and that the modified Allen test may unnecessarily exclude some patients from radial artery catheterization. However, the number of patients who underwent radial artery catheterization was not reported, and the value of either test for predicting ischemic complications following radial artery catheterization was not assessed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     ARRHYTHMIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of arrhythmias and conduction disturbances can occur during catheterization. The most common, ventricular premature beats, may be induced by catheter introduction into the right or left ventricle, and are generally without clinical importance or impact.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Ventricular tachycardia or fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular tachycardia or fibrillation is rare complications of catheterization, occurring in 0.4 percent of cases in the second registry of the Society for Cardiac Angiography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2\">",
"     2",
"    </a>",
"    ]. These arrhythmias may result from excess catheter manipulation or, more commonly, from intracoronary contrast injection. This complication occurs more commonly when ionic and hyperosmolar contrast agents are used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Atrial arrhythmias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atrial arrhythmias can be induced by cardiac catheterization, especially in response to catheter placement into or out of the right atrium during right heart catheterization. These arrhythmias usually do not require immediate treatment unless they produce ischemia or hemodynamic instability.",
"   </p>",
"   <p>",
"    Atrial flutter is generally well tolerated and can be treated with burst atrial pacing, or electrical or pharmacologic cardioversion. Atrial fibrillation, on the other hand, can cause clinical sequelae in the setting of a rapid ventricular response or if the loss of atrial systole results in hypotension, as in a patient with mitral stenosis or diastolic ventricular dysfunction. Synchronized cardioversion should be performed immediately in patients who are hemodynamically unstable. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22426?source=see_link&amp;anchor=H8701654#H8701654\">",
"     \"Restoration of sinus rhythm in atrial fibrillation\", section on 'DC cardioversion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Bradycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bradycardia commonly occurs during coronary angiography, most often at the end of the injection of ionic contrast into the right coronary artery. Forceful coughing helps to clear the contrast, support perfusion, and restore normal cardiac rhythm.",
"   </p>",
"   <p>",
"    Vasovagal reactions, which can include bradycardia, hypotension, yawning,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sweating, are seen in up to 3 percent of patients, particularly if they have pain or are anxious [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2\">",
"     2",
"    </a>",
"    ]. These reactions may occur with palpation or compression of the artery prior to needle access.",
"   </p>",
"   <p>",
"    Treatment usually consists of volume administration,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    (0.5 to 1.0 mg intravenously), and removal of the painful stimulus. Patients with critical coronary or valvular disease may undergo irreversible decompensation from vagally-mediated hypotension. As a result, rapid reversal of hypotension is crucial in this setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Conduction disturbances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conduction disturbances are a rare cause of bradycardia in the catheterization laboratory. Patients with pre-existing left bundle branch block may develop asystole with right heart catheterization. Patients with pre-existing right bundle branch block may develop asystole during left heart catheterization.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     Atropine",
"    </a>",
"    is rarely helpful in patients who develop complete heart block, but its administration is still recommended. Coughing may help support the circulation while the right heart catheter is exchanged for a temporary pacing wire. Prophylactic placement of a temporary pacemaker is not necessary, even in patients with bundle branch block or intervention in the right coronary artery.",
"   </p>",
"   <p>",
"    Frank asystole is rare and there is generally sufficient time for insertion of a pacing wire through a venous sheath [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     PERFORATION OF THE HEART OR GREAT VESSELS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perforation is an extremely rare complication of cardiac catheterization. Higher risk procedures are those that involve stiffer catheters, including transseptal catheterization, endomyocardial biopsy, balloon valvuloplasty, needle pericardiocentesis, and placement of a pacing catheter. Older adult women appear to be at particular risk.",
"   </p>",
"   <p>",
"    Cardiac perforation is generally heralded by bradycardia and hypotension due to vagal stimulation induced by blood in the pericardium. If the patient is hemodynamically stable, echocardiography is suggested to document the presence of blood in the pericardial space. However, emergent pericardiocentesis should be performed via the subxiphoid approach in the presence of hemodynamic instability.",
"   </p>",
"   <p>",
"    Since pericardiocentesis is itself associated with complications, it is best performed under echocardiographic guidance or with pressure monitoring. In a study of 91 cases of acute tamponade during catheterization, pericardiocentesis was the only therapy necessary in 82 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reversal of anticoagulation may cause blood in the pericardial space to \"gel.\" As a result, we generally try to aspirate the majority of the blood in the pericardial space prior to the administration of protamine&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     ALLERGIC REACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic reactions during catheterization may be precipitated by three agents: the local anesthetic, the contrast agent, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/9/11413?source=see_link\">",
"     protamine sulfate",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Local anesthetic",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients claiming previous reaction to a local anesthetic, the use of a preservative-free agent (such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/55/40821?source=see_link\">",
"     mepivacaine",
"    </a>",
"    ) may be a safe alternative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Iodinated contrast agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reaction to the contrast agent occurs in up to 1 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. The risk of such a reaction is highest in patients with a history of prior contrast reactions. Other conditions, such as asthma and other atopic diseases, also confer some risk. Immediate hypersensitivity reactions to radiocontrast media are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/36/31305?source=see_link\">",
"     \"Immediate hypersensitivity reactions to radiocontrast media: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several steps that can reduce the incidence of a reaction in a high-risk patient:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Premedication with corticosteroids and H1 antihistamines can reduce the incidence of a severe reaction (eg, bronchospasm or shock) to below 1 percent (",
"      <a class=\"graphic graphic_table graphicRef59096 \" href=\"mobipreview.htm?4/47/4860\">",
"       table 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The patient should receive a nonionic contrast agent. The incidence of crossreactivity in patients who have had previous reactions to older agents is low, although all patients with previous reactions should be premedicated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"       1",
"      </a>",
"      ]. In the past, nonionic contrast agents were used selectively, given their higher cost. However, the cost of nonionic contrast has fallen significantly. Thus, we recommend using nonionic contrast in all patients undergoing coronary angiography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If a severe reaction does occur, it should be treated in the same manner as anaphylaxis, and can be sometimes be reversed by using boluses of intravenous epinephrine (1:10,000 epinephrine so that 1 mL = 0.1 mg). One mL of this solution should be administered approximately every minute until the arterial pressure is restored. However, the rapidity of dosing must be adjusted by the degree of hypotension and the level of assessed hypoperfusion. It is rare for a patient to require a total dose of more than 1.0 mg (10 mL).",
"   </p>",
"   <p>",
"    Contrast-induced acute renal failure represents another complication that is discussed below. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Contrast nephropathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Protamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic reactions to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/9/11413?source=see_link\">",
"     protamine sulfate",
"    </a>",
"    occur occasionally, more often in insulin-dependent diabetic patients who have received NPH insulin (which contains protamine) in the past [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/1\">",
"     1",
"    </a>",
"    ]. The rapid administration of protamine sulfate can also provoke back pain of unknown etiology.",
"   </p>",
"   <p>",
"    In current practice, protamine is rarely administered. Most diagnostic catheterizations are done without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    anticoagulation and in most interventional procedures the heparin is either allowed to wear off over the next two to three hours prior to sheath removal, or the sheath is removed in the fully anticoagulated state using an arterial closure device.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     ATHEROEMBOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the process of cardiac catheterization, atheromatous debris is often scraped from the aortic wall. This debris can cause systemic embolization, including cutaneous, renal, retinal, cerebral, and gastrointestinal emboli (",
"    <a class=\"graphic graphic_picture graphicRef58761 \" href=\"mobipreview.htm?2/15/2289\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef71860 \" href=\"mobipreview.htm?39/58/40866\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef63740 \" href=\"mobipreview.htm?23/3/23601\">",
"     picture 3",
"    </a>",
"    ). To minimize the risk of stroke or visual impairment, arterial catheter exchanges are best performed over a wire in the descending aorta at the level of the diaphragm (for closed loop catheters) and in the ascending aorta for angiographic catheters. Once arterial access has been obtained, the practice of readvancing the guidewire through the infrarenal aorta rather than exchanging it through a catheter should be avoided.",
"   </p>",
"   <p>",
"    The high rate of release of atheromatous debris was illustrated in a series of 1000 patients undergoing percutaneous coronary intervention: 51 percent had aortic atheromatous material retrieved from the catheter after back flow of blood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/42\">",
"     42",
"    </a>",
"    ]. There were no associated in-hospital ischemic complications, probably due to sufficient withdrawal of blood containing the debris prior to the injection of contrast.",
"   </p>",
"   <p>",
"    The reported incidence of atheroembolic events varies from 0.6 to 0.9 percent in retrospective studies to 1.4 to 1.9 percent in prospective series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=see_link\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features of atheroembolism after diagnostic cardiac catheterization were examined in a prospective evaluation of 1786 patients &ge;40 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/44\">",
"     44",
"    </a>",
"    ]. The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      25 patients (1.4 percent) were diagnosed with atheroembolism; 12 had cutaneous signs (eg, \"blue toes\" syndrome, livedo reticularis) (",
"      <a class=\"graphic graphic_picture graphicRef58761 \" href=\"mobipreview.htm?2/15/2289\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef71860 \" href=\"mobipreview.htm?39/58/40866\">",
"       picture 2",
"      </a>",
"      ) and 16 had acute renal failure that was considered to be atheroembolic in origin because it persisted for at least two weeks (while contrast nephropathy typically reverses within the first week). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Acute renal failure'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Eosinophil counts were significantly higher in patients suffering from atheroembolism both before and after catheterization.",
"     </li>",
"     <li>",
"      Four patients with atheroembolism died in hospital (16 percent); all had progressive renal dysfunction. The mortality rate was much lower (0.5 percent) in the patients without atheroembolism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of atheroembolism is largely supportive. Therapies that have been evaluated are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=see_link&amp;anchor=H13#H13\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     ACUTE RENAL FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three major causes of renal dysfunction related to cardiac catheterization: contrast-induced acute renal failure, renal atheroemboli, and hemodynamic instability with renal hypoperfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Contrast nephropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least 5 percent of patients who undergo cardiac catheterization experience a transient rise in the plasma creatinine concentration of more than 1.0",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (88",
"    <span class=\"nowrap\">",
"     micromol/L)",
"    </span>",
"    due to contrast-induced renal dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/45\">",
"     45",
"    </a>",
"    ]. However, there is substantial variability in risk among patients, some of whom have a risk that exceeds 50 percent. The risk is greatest in patients with moderate to severe renal insufficiency and diabetes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/13/10457?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The plasma creatinine concentration usually returns to baseline within seven days, and less than 1 percent of patients, usually diabetic patients with underlying severe chronic kidney disease, go on to require chronic hemodialysis.",
"   </p>",
"   <p>",
"    Nonionic low osmolal contrast agents are now administered for the majority of radiologic procedures using intravascular contrast media, as a result of increased patient tolerability and decreased hypersensitivity reactions. However, in patients at risk for contrast nephropathy, we prefer the use of iso-osmolal agents (approximately 290",
"    <span class=\"nowrap\">",
"     mosmol/kg)",
"    </span>",
"    rather than low osmolal agents (500 to 850",
"    <span class=\"nowrap\">",
"     mosmol/kg)",
"    </span>",
"    because of a lower risk of contrast nephropathy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35498?source=see_link\">",
"     \"Prevention of contrast-induced nephropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2007 focused update of the",
"    <span class=\"nowrap\">",
"     ACC/AHA/SCAI",
"    </span>",
"    2005 PCI guidelines recommended the use of iso-osmolal in preference to low osmolal agents in patients with chronic kidney disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Renal atheroemboli",
"    </span>",
"    &nbsp;&mdash;&nbsp;The kidney is one of the principal end organs that may be affected by atheroembolic events. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Atheroembolism'",
"    </a>",
"    above.) There are three main findings that suggest that atheroemboli rather than contrast nephropathy is responsible for the development of acute renal failure after catheterization:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of other signs of embolization such as blue toes (",
"      <a class=\"graphic graphic_picture graphicRef58761 \" href=\"mobipreview.htm?2/15/2289\">",
"       picture 1",
"      </a>",
"      ), livedo reticularis (",
"      <a class=\"graphic graphic_picture graphicRef71860 \" href=\"mobipreview.htm?39/58/40866\">",
"       picture 2",
"      </a>",
"      ), Hollenhorst plaques in the retina (",
"      <a class=\"graphic graphic_picture graphicRef63740 \" href=\"mobipreview.htm?23/3/23601\">",
"       picture 3",
"      </a>",
"      ),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      abdominal pain.",
"     </li>",
"     <li>",
"      Transient eosinophilia and hypocomplementemia.",
"     </li>",
"     <li>",
"      Persistent renal failure after seven days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=see_link\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=see_link\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a review of 1786 consecutive patients undergoing cardiac catheterization, acute renal failure developed in 0.9 percent overall and in 64 percent of those with evidence of any atheroembolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/44\">",
"     44",
"    </a>",
"    ]. In this report, acute renal failure was considered to be due to renal atheroembolism if it had persisted for at least two weeks, well beyond the time at which contrast nephropathy should have resolved.",
"   </p>",
"   <p>",
"    Treatment for this condition is largely supportive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=see_link&amp;anchor=H13#H13\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheterization procedures are performed using sterile technique. Thus, both local infection and bacteremia are rare and endocarditis prophylaxis during cardiac catheterization is not recommended for patients with valvular disease. Infection is approximately 10 times more common with the brachial approach compared to the femoral approach (0.6 versus 0.06 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2-7\">",
"     2-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infection control guidelines for the cardiac catheterization laboratory were updated in 2006 by the Society for Cardiovascular Angiography and Interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/42/42665/abstract/47\">",
"     47",
"    </a>",
"    ]. These guidelines emphasize the importance of handwashing caps, gowns, gloves, and masks to protect the patient against bacterial infection, and measures such as eye wear and vaccination for hepatitis B to protect laboratory personnel.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     RADIATION EXPOSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing diagnostic and interventional cardiac catheterization receive substantial radiation exposure. This issue is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/2/14376?source=see_link\">",
"     \"Radiation dose and risk of malignancy from cardiovascular imaging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     ENDOMYOCARDIAL BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endomyocardial biopsy of right ventricular tissue is made using a relatively stiff catheter. Complications such as perforation of the heart or great vessels, life threatening arrhythmias, or heart block requiring permanent pacing occur uncommonly. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7592?source=see_link&amp;anchor=H19#H19\">",
"     \"Endomyocardial biopsy\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/53/35667?source=see_link\">",
"       \"Patient information: Cardiac catheterization (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186337600\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The risk of a major complication (death, myocardial infarction, or major embolization) during or after diagnostic cardiac catheterization is well below 1 percent. As a result, the risk-to-benefit ratio still favors performing this procedure as a part of the evaluation of potentially fatal or lifestyle-limiting cardiac disease.",
"     </li>",
"     <li>",
"      Mortality is under 0.1 percent. Risk factors for death include advancing age, higher New York Heart Association heart failure class, left main coronary artery disease, severe left ventricular dysfunction, as well as the presence of valvular heart disease, chronic kidney disease, diabetes mellitus requiring insulin therapy, peripheral artery disease, cerebrovascular disease, and pulmonary insufficiency. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Death'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of myocardial infarction is under 0.1 percent. Risk factors include the extent of disease, the presence of insulin dependent diabetes mellitus, and recent non-ST elevation myocardial infarction. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Myocardial infarction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of stroke has been reported to be as high as 0.2 to 0.4 percent. Risk factors for stroke include the severity of coronary artery disease, the length of fluoroscopy time, diabetes, hypertension, prior stroke, or renal failure. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Stroke and transient ischemic attack'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Local complications at the site of catheter insertion are among the most common problems seen after cardiac catheterization. These problems may include acute thrombosis, distal embolization, dissection, poorly controlled bleeding, hematoma, retroperitoneal hemorrhage, pseudoaneurysm, or arteriovenous fistula. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Local vascular complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other potentially serious complications include: ventricular tachyarrhythmias, severe bradycardia, allergic reactions, atheroembolism, and acute kidney injury (contrast nephropathy). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Arrhythmias'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H24\">",
"       'Allergic reactions'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H28\">",
"       'Atheroembolism'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H29\">",
"       'Acute renal failure'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Baim, DS, Grossman, W. Complications of cardiac catheterization. In: Cardiac Catheterization, Angiography and Intervention, Baim, DS, Grossman, W (Eds), Williams &amp; Wilkins, Baltimore 1996. p.17.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/2\">",
"      Johnson LW, Lozner EC, Johnson S, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. Cathet Cardiovasc Diagn 1989; 17:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/3\">",
"      Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/4\">",
"      Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovasc Diagn 1982; 8:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/5\">",
"      Noto TJ Jr, Johnson LW, Krone R, et al. Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&amp;I). Cathet Cardiovasc Diagn 1991; 24:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/6\">",
"      Laskey W, Boyle J, Johnson LW. Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography &amp; Interventions. Cathet Cardiovasc Diagn 1993; 30:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/7\">",
"      Wyman RM, Safian RD, Portway V, et al. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988; 12:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/8\">",
"      King KM, Ghali WA, Faris PD, et al. Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA 2004; 291:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/9\">",
"      Hemmelgarn BR, Southern DA, Humphries KH, et al. Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J 2006; 27:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/10\">",
"      Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/11\">",
"      Segal AZ, Abernethy WB, Palacios IF, et al. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology 2001; 56:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/12\">",
"      Hamon M, Baron JC, Viader F, Hamon M. Periprocedural stroke and cardiac catheterization. Circulation 2008; 118:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/13\">",
"      Omran H, Schmidt H, Hackenbroch M, et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 2003; 361:1241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/14\">",
"      Chambers J, Bach D, Dumesnil J, et al. Crossing the aortic valve in severe aortic stenosis: no longer acceptable? J Heart Valve Dis 2004; 13:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/15\">",
"      B&uuml;sing KA, Schulte-Sasse C, Fl&uuml;chter S, et al. Cerebral infarction: incidence and risk factors after diagnostic and interventional cardiac catheterization--prospective evaluation at diffusion-weighted MR imaging. Radiology 2005; 235:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/16\">",
"      Lund C, Nes RB, Ugelstad TP, et al. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J 2005; 26:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/17\">",
"      Pracyk JB, Wall TC, Longabaugh JP, et al. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol 1998; 81:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/18\">",
"      Ward SR, Casale P, Raymond R, et al. Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol 1998; 81:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/19\">",
"      Kapadia SR, Raymond R, Knopf W, et al. The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol 2001; 87:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/20\">",
"      Silber S, Gershony G, Sch&ouml;n B, et al. A novel vascular sealing device for closure of percutaneous arterial access sites. Am J Cardiol 1999; 83:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/21\">",
"      Silber S, Tofte AJ, Kjellevand TO, et al. Final report of the European multi-center registry using the Duett vascular sealing device. Herz 1999; 24:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/22\">",
"      Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate aNd discharge (STAND I and STAND II) trials. Am J Cardiol 2000; 85:864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/23\">",
"      Koreny M, Riedm&uuml;ller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 2004; 291:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/24\">",
"      Nikolsky E, Mehran R, Halkin A, et al. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol 2004; 44:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/25\">",
"      Geary K, Landers JT, Fiore W, Riggs P. Management of infected femoral closure devices. Cardiovasc Surg 2002; 10:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/26\">",
"      Cherr GS, Travis JA, Ligush J Jr, et al. Infection is an unusual but serious complication of a femoral artery catheterization site closure device. Ann Vasc Surg 2001; 15:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/27\">",
"      El-Jack SS, Ruygrok PN, Webster MW, et al. Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation. Am J Cardiol 2006; 97:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/28\">",
"      Krueger K, Zaehringer M, Strohe D, et al. Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. Radiology 2005; 236:1104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/29\">",
"      Katzenschlager R, Ugurluoglu A, Ahmadi A, et al. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology 1995; 195:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/30\">",
"      Webber GW, Jang J, Gustavson S, Olin JW. Contemporary management of postcatheterization pseudoaneurysms. Circulation 2007; 115:2666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/31\">",
"      Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992; 69:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/32\">",
"      Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993; 88:1569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/33\">",
"      Paulson EK, Sheafor DH, Kliewer MA, et al. Treatment of iatrogenic femoral arterial pseudoaneurysms: comparison of US-guided thrombin injection with compression repair. Radiology 2000; 215:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/34\">",
"      La Perna L, Olin JW, Goines D, et al. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation 2000; 102:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/35\">",
"      Hamraoui K, Ernst SM, van Dessel PF, et al. Efficacy and safety of percutaneous treatment of iatrogenic femoral artery pseudoaneurysm by biodegradable collagen injection. J Am Coll Cardiol 2002; 39:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/36\">",
"      Greenwood MJ, Della-Siega AJ, Fretz EB, et al. Vascular communications of the hand in patients being considered for transradial coronary angiography: is the Allen's test accurate? J Am Coll Cardiol 2005; 46:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/37\">",
"      Barbeau GR, Arsenault F, Dugas L, et al. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen's test in 1010 patients. Am Heart J 2004; 147:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/38\">",
"      Benit E, Vranckx P, Jaspers L, et al. Frequency of a positive modified Allen's test in 1,000 consecutive patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 1996; 38:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/39\">",
"      Hovagim AR, Katz RI, Poppers PJ. Pulse oximetry for evaluation of radial and ulnar arterial blood flow. J Cardiothorac Anesth 1989; 3:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/40\">",
"      Harvey JR, Wyman RM, McKay RG, Baim DS. Use of balloon flotation pacing catheters for prophylactic temporary pacing during diagnostic and therapeutic catheterization procedures. Am J Cardiol 1988; 62:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/41\">",
"      Tsang TS, Freeman WK, Barnes ME, et al. Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. The Mayo Clinic experience. J Am Coll Cardiol 1998; 32:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/42\">",
"      Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol 1998; 32:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/43\">",
"      Bashore TM, Gehrig T. Cholesterol emboli after invasive cardiac procedures. J Am Coll Cardiol 2003; 42:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/44\">",
"      Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/45\">",
"      Tommaso CL. Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 1994; 31:316.",
"     </a>",
"    </li>",
"    <li>",
"     King SB, 3rd, Smith, SC Jr, Hirshfeld, JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008; 117:261. Available at: www.circ.ahajournals.org (accessed January 29, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/42/42665/abstract/47\">",
"      Chambers CE, Eisenhauer MD, McNicol LB, et al. Infection control guidelines for the cardiac catheterization laboratory: society guidelines revisited. Catheter Cardiovasc Interv 2006; 67:78.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1470 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-85.214.214.87-D5DBC4741A-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42665=[""].join("\n");
var outline_f41_42_42665=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H186337600\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MAJOR COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Role of valvular aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Asymptomatic embolic events",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LOCAL VASCULAR COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hemostasis at the access site",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H678090977\">",
"      - Mechanical clamp",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H678090984\">",
"      - Closure devices",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Prior warfarin therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hematoma formation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Retroperitoneal extension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Arteriovenous fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Pseudoaneurysm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Arterial thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Radial artery access",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Is the palmar arch intact?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      ARRHYTHMIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Ventricular tachycardia or fibrillation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Atrial arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Bradycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Conduction disturbances",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      PERFORATION OF THE HEART OR GREAT VESSELS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      ALLERGIC REACTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Local anesthetic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Iodinated contrast agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Protamine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      ATHEROEMBOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      ACUTE RENAL FAILURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Contrast nephropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      RADIATION EXPOSURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      ENDOMYOCARDIAL BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186337600\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1470\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1470|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/50/14127\" title=\"figure 1\">",
"      Hemostatic closure device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/1/10260\" title=\"figure 2\">",
"      Anatomy of the radial artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/61/4049\" title=\"figure 3\">",
"      Modified Allen test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1470|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/15/2289\" title=\"picture 1\">",
"      Blue toe syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/58/40866\" title=\"picture 2\">",
"      Livedo reticularis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/3/23601\" title=\"picture 3\">",
"      Hollenhorst plaque retinal artery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1470|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/16/28939\" title=\"table 1A\">",
"      Risk of cardiac catheterization and coronary angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/26/6572\" title=\"table 1B\">",
"      Predictors of complications at the time of coronary angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/31/38395\" title=\"table 1C\">",
"      Contraindications to coronary angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 2\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/52/43851\" title=\"table 3\">",
"      Risk factors for intracranial hemorrhage with thrombolysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/47/4860\" title=\"table 4\">",
"      Pretreatment for patients with prior RCM reactions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/8/27786?source=related_link\">",
"      Antithrombotic therapy for percutaneous coronary intervention: General use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/13/13528?source=related_link\">",
"      Clinical presentation, evaluation, and treatment of renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/15/31994?source=related_link\">",
"      Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/26/7592?source=related_link\">",
"      Endomyocardial biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/43/1721?source=related_link\">",
"      Fibrinolytic therapy in acute ST elevation myocardial infarction: Initiation of therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/36/31305?source=related_link\">",
"      Immediate hypersensitivity reactions to radiocontrast media: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/13/10457?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/53/35667?source=related_link\">",
"      Patient information: Cardiac catheterization (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/48/38666?source=related_link\">",
"      Periprocedural complications of percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/42/35498?source=related_link\">",
"      Prevention of contrast-induced nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/2/14376?source=related_link\">",
"      Radiation dose and risk of malignancy from cardiovascular imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22426?source=related_link\">",
"      Restoration of sinus rhythm in atrial fibrillation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_42_42666="ECG iof inferior MI with anterior ischemia";
var content_f41_42_42666=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54339&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1226px;\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    ECG iof inferior MI with anterior ischemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram showing ischemic changes in two areas of the myocardium: inferior myocardial infarction (Q waves and ST elevations in leads II, III, and aVF); and anterior ischemia (ST depressions in leads V2 and V3).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 594px\">",
"   <div class=\"ttl\">",
"    Normal ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 337px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal electrocardiogram showing normal sinus rhythm at a rate of 75 beats/min, a PR interval of 0.14 sec, a QRS interval of 0.10 sec, and a QRS axis of approximately 75&deg;.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42666=[""].join("\n");
var outline_f41_42_42666=null;
var title_f41_42_42667="AIs fracture";
var content_f41_42_42667=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F70977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F70977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fractures in the major randomized aromatase inhibitor trials",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Trial",
"      </td>",
"      <td class=\"subtitle1\">",
"       N/n",
"      </td>",
"      <td class=\"subtitle1\">",
"       F/U, mo",
"      </td>",
"      <td class=\"subtitle1\">",
"       Treatment",
"      </td>",
"      <td class=\"subtitle1\">",
"       Clinical fracture rate, percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"5\">",
"       AI vs TAM",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       ATAC",
"      </td>",
"      <td>",
"       9366/609",
"      </td>",
"      <td>",
"       100",
"      </td>",
"      <td>",
"       ANA vs TAM",
"      </td>",
"      <td>",
"       11.0 vs 7.7 [p&lt;0.001]",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       BIG 1-98",
"      </td>",
"      <td>",
"       4922/352",
"      </td>",
"      <td>",
"       51",
"      </td>",
"      <td>",
"       LET vs TAM",
"      </td>",
"      <td>",
"       8.6 vs 5.8 [p&lt;0.01]",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"5\">",
"       AI after 2-3 years of TAM",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       IES",
"      </td>",
"      <td>",
"       4724/277",
"      </td>",
"      <td>",
"       58",
"      </td>",
"      <td>",
"       EXE vs TAM",
"      </td>",
"      <td>",
"       7.0 vs 5.0 [p = 0.003]",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       ABCSG8/ARNO",
"      </td>",
"      <td>",
"       3224/50",
"      </td>",
"      <td>",
"       28",
"      </td>",
"      <td>",
"       ANA vs TAM",
"      </td>",
"      <td>",
"       2.0 vs 1.0 [p = 0.015]",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"5\">",
"       AI after 5 years of TAM",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       MA-17",
"      </td>",
"      <td>",
"       5187/256",
"      </td>",
"      <td>",
"       30",
"      </td>",
"      <td>",
"       LET vs Placebo",
"      </td>",
"      <td>",
"       5.3 vs 4.6 [p = 0.25]",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ANA: anastrozole; TAM: tamoxifen; EXE: exemestane; LET: letrozole; F/U: follow-up; BMD: bone mineral density; N: number of patients treated; n: total number of fractures.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pant, S, Shapiro, CL. Aromatase inhibitor-associated bone loss. Drugs 2008; 68:2591. Copyright &copy;2008 Adis Data Information BV.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42667=[""].join("\n");
var outline_f41_42_42667=null;
var title_f41_42_42668="Anti seizure medications PI";
var content_f41_42_42668=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F61234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F61234&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anti-seizure medications",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug name",
"      </td>",
"      <td class=\"subtitle1\">",
"       Tablet/capsule",
"      </td>",
"      <td class=\"subtitle1\">",
"       Liquid/syrup",
"      </td>",
"      <td class=\"subtitle1\">",
"       Side effects*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Carbamazepine (Tegretol&reg;, Carbatrol&reg;)",
"      </td>",
"      <td>",
"       X (including chewable)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Diarrhea, rash, serious allergic reaction, low blood sodium levels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ethosuximide (Zarontin&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Trouble sleeping, hyperactivity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lacosamide (Vimpat&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Heart rhythm changes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rufinamide (Banzel&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Heart rhythm changes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Gabapentin (Neurontin&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Weight gain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lamotrigine (Lamictal&reg;",
"      </td>",
"      <td>",
"       X (including chewable)",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Rash, with risk of a serious allergic reaction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Levtiracetam (Keppra&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Aggressive behavior, irritability",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Oxcarbazepine (Trileptal&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Rash, serious allergic reaction, low blood sodium levels",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phenobarbital (Luminal&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Slowed thinking, rash, hyperactivity and other behavioral changes in children",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phenytoin (Dilantin&reg;, Phenytek&reg;)",
"      </td>",
"      <td>",
"       X (including chewable)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Abnormal growth of the gums, increased body hair, rash, swollen lymph nodes (glands)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pregabalin (Lyrica&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Weight gain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tiagabine (Gabitril&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Tremor, difficulty concentrating, abdominal pain",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Topiramate (Topamax&reg;)",
"      </td>",
"      <td>",
"       X (capsule may be opened and sprinkled on food)",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Weight loss, numbness and tingling in the hands and feet; difficulty thinking clearly",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Valproic acid (Depakote&reg;, Depakene&reg;)",
"      </td>",
"      <td>",
"       X (capsule may be opened and sprinkled on food)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       Weight gain, hair loss, bruising, tremor, liver toxicity",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Zonisamide (Zonegran&reg;)",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       Weight loss, difficulty thinking clearly",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Many of these medications can also cause sedation and/or fatigue, dizziness, double vision and nausea.",
"    <div class=\"footnotes\">",
"     * These side effects occur in some, not most patients.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42668=[""].join("\n");
var outline_f41_42_42668=null;
var title_f41_42_42669="Diagnosis of COPD I";
var content_f41_42_42669=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F53303%7EPULM%2F61983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F53303%7EPULM%2F61983&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnosis of chronic obstructive pulmonary disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\">",
"        Smoking history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Age at initiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Average amount smoked per day since initiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Date when stopped smoking or a current smoker",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\">",
"        Environmental history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        The chronologically taken environmental history may disclose important risk factors for COPD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Asthma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_single\">",
"        Dyspnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ask about the amount of effort required to induce uncomfortable breathing. Many individuals will deny symptoms of dyspnea, but will have reduced their activity levels substantially.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_single\">",
"        Cough",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Cough with or without sputum production should be an indication for spirometric testing. The presence of chronic cough and sputum has been used to define chronic bronchitis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_single\">",
"        Wheezing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Wheezing or squeaky noises occurring during breathing indicate the presence of airflow obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_single\">",
"        Acute chest illnesses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Inquire about occurrence and frequency of episodes of increased cough and sputum with wheezing, dyspnea, or fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Physical examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        All physical findings are generally present only with severe disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Chest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The presence of emphysema (only when severe) is indicated by: overdistention of the lungs in the stable state (chest held near full inspiratory position at end of normal expiration, low diaphragmatic position), decreased intensity of breath and heart sounds, and prolonged expiratory phase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Evidence of airflow obstruction: wheezes during auscultation on slow or forced breathing and prolongation of forced expiratory time",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Frequently observed with severe disease (characteristic, but not diagnostic): pursed-lip breathing, use of accessory respiratory muscles, retraction of lower interspaces",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Unusual positions to relieve dyspnea at rest",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Digital clubbing is NOT typical in COPD (even with associated hypoxemia) and suggests other diagnoses (eg, lung cancer, bronchiectasis, pulmonary fibrosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild dependent edema may be seen in the absence of right heart failure",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnosis of chronic obstructive pulmonary disease: PFTs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Spirometry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spirometry is the essential test to confirm the diagnosis and establish the staging of COPD. If values are abnormal, a post-bronchodilator test may be indicated. Airflow limitation that is irreversible or only partially reversible with bronchodilator is suggestive of COPD rather than asthma. A postbronchodilator ratio of FEV1/FVC &lt;0.7 or &lt;LLN of FEV1/FVC is used to establish the presence of airflow limitation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         In the presence of a low FEV1/FVC, the percent of predicted FEV1 is used to determine the severity of airflow limitation.",
"        </p>",
"        <p>",
"         GOLD 1: Mild (FEV1 &ge;80 percent predicted)",
"        </p>",
"        <p>",
"         GOLD 2: Moderate (50 percent predicted &le;FEV1 &lt;80 percent predicted)",
"        </p>",
"        <p>",
"         GOLD 3: Severe (30 percent predicted &le;FEV1 &lt;50 percent predicted)",
"        </p>",
"        <p>",
"         GOLD 4: Very severe (FEV1 &lt;30 percent predicted)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Lung volumes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Body plethysmography to assess lung volumes is not necessary except in patients with a low FVC on spirometry (&lt;80 percent predicted) or when concomitant interstitial lung disease is suspected.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Diffusing capacity for carbon monoxide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Measurement of DLCO can help establish the presence of emphysema, but is not necessary for the routine diagnosis of COPD.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Chest radiography",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Only diagnostic of severe emphysema, but is frequently obtained to exclude other lung diseases.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Arterial blood gases (ABGs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild and moderate airflow obstruction - ABG usually not needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Moderately severe airflow obstruction - ABG is optional, but oximetry should be done. ABGs are obtained if oxygen saturation is &lt;92 percent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Severe and very severe airflow obstruction - ABGs are essential to assess for hypercapnia.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     PFTs: pulmonary function tests; COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; LLN: lower limit of normal; GOLD: Global Initiative for Chronic Obstructive Lung Disease; DLCO: diffusing capacity for carbon monoxide; ABG: arterial blood gas.",
"     <br/>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42669=[""].join("\n");
var outline_f41_42_42669=null;
var title_f41_42_42670="Late potentials in ARVC";
var content_f41_42_42670=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Late potentials in arrhythmogenic right ventricular cardiomyopathy (ARVC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 175px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bipolar leads recorded from the thorax over the right precordium in a patient with arrhythmogenic right ventricular cardiomyopathy (ARVC) shows QRS prolongation (220 msec) due to multiple late potentials after the QRS complex (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from: Podrid PJ, Kowey PR (Eds). Cardiac Arrhythmia. Mechanisms, Diagnosis, and Management, Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42670=[""].join("\n");
var outline_f41_42_42670=null;
var title_f41_42_42671="Superficial veins of lower leg posterior view";
var content_f41_42_42671=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F52340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F52340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial veins of lower leg, posterior view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 403px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_42_42671=[""].join("\n");
var outline_f41_42_42671=null;
       